<SEC-DOCUMENT>0000921895-21-000865.txt : 20210326
<SEC-HEADER>0000921895-21-000865.hdr.sgml : 20210326
<ACCEPTANCE-DATETIME>20210326165931
ACCESSION NUMBER:		0000921895-21-000865
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210326
DATE AS OF CHANGE:		20210326

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KOHLS Corp
		CENTRAL INDEX KEY:			0000885639
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DEPARTMENT STORES [5311]
		IRS NUMBER:				391630919
		STATE OF INCORPORATION:			WI
		FISCAL YEAR END:			0130

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11084
		FILM NUMBER:		21778269

	BUSINESS ADDRESS:	
		STREET 1:		N56 W17000 RIDGEWOOD DR
		CITY:			MENOMONEE FALLS
		STATE:			WI
		ZIP:			53051
		BUSINESS PHONE:		262 703 7000

	MAIL ADDRESS:	
		STREET 1:		N56 W17000 RIDGEWOOD DR
		CITY:			MENOMONEE FALLS
		STATE:			WI
		ZIP:			53051

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KOHLS CORPORATION
		DATE OF NAME CHANGE:	19930328

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Macellum Advisors GP, LLC
		CENTRAL INDEX KEY:			0001640326
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		99 HUDSON STREET
		STREET 2:		5TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212.958.3008

	MAIL ADDRESS:	
		STREET 1:		99 HUDSON STREET
		STREET 2:		5TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>dfan14a09050035_03262021.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Rule
14a-101)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">INFORMATION REQUIRED IN PROXY STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">SCHEDULE 14A INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proxy Statement Pursuant to Section 14(a) of
The Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Amendment No. )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Filed by the Registrant &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Filed by a Party other than the Registrant &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Preliminary Proxy Statement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Definitive Proxy Statement</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9746;</TD><TD>Definitive Additional Materials</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Soliciting Material Under Rule 14a-12</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; text-align: center; vertical-align: top; border-bottom: Black 0.5pt solid"><FONT STYLE="text-transform: uppercase">KOHL&rsquo;S CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top"><P>(Name of Registrant as Specified in Its Charter)</P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top; border-bottom: Black 0.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">MACELLUM BADGER FUND, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">MACELLUM BADGER FUND II, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">MACELLUM ADVISORS, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">MACELLUM ADVISORS GP, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">JONATHAN DUSKIN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">LEGION PARTNERS HOLDINGS, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">LEGION PARTNERS, L.P. I</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">LEGION PARTNERS, L.P. II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">LEGION PARTNERS SPECIAL OPPORTUNITIES, L.P.
XV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">LEGION PARTNERS, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">LEGION PARTNERS ASSET MANAGEMENT, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CHRISTOPHER S. KIPER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">RAYMOND T. WHITE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA CATALYST INSTITUTIONAL, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA CATALYST, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA MERLIN, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA MERLIN INSTITUTIONAL, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA CATALYST SPV I LP SERIES M</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA CATALYST SPV I LP SERIES N</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA CATALYST SPV I LP SERIES O</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA CATALYST SPV I LP SERIES P</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA CATALYST SPV I SPC LTD SEGREGATED PORTFOLIO
G</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA ADVISORS, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA HOLDINGS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA FAMILY WEALTH ADVISORS, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">THE ANCORA GROUP INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">INVERNESS HOLDINGS, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ANCORA ALTERNATIVES, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">FREDERICK DISANTO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">4010 PARTNERS, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">4010 CAPITAL, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">4010 GENERAL PARTNER, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">STEVEN E. LITT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">MARGARET L. JENKINS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">JEFFREY A. KANTOR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">THOMAS A. KINGSBURY</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">CYNTHIA S. MURRAY</P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top"><P>(Name of Persons(s) Filing Proxy Statement, if Other Than the Registrant)</P>

</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9746;</TD><TD>No fee required.</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>Title of each class of securities to which transaction applies:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>Aggregate number of securities to which transaction applies:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>Proposed maximum aggregate value of transaction:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD>Total fee paid:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Fee paid previously with preliminary materials:</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of
its filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>Amount previously paid:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>Form, Schedule or Registration Statement No.:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>Filing Party:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>Date Filed:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">2021 ANNUAL MEETING OF SHAREHOLDERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">OF</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">KOHL&rsquo;S CORPORATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">___________________________</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SUPPLEMENT DATED MARCH 26, 2021 TO THE
PROXY STATEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">OF<BR>
MACELLUM BADGER FUND, LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>DATED MARCH 15,
2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">___________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B>PLEASE SIGN, DATE
AND MAIL THE ENCLOSED <U>WHITE</U> PROXY CARD TODAY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Dear Fellow Shareholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Macellum Badger Fund, LP,
a Delaware limited partnership (&ldquo;Macellum Badger&rdquo;), and the other participants in this solicitation (collectively,
the &ldquo;Investor Group&rdquo; or &ldquo;we&rdquo;) are significant shareholders of Kohl&rsquo;s Corporation, a Wisconsin corporation
(&ldquo;Kohl&rsquo;s&rdquo; or the &ldquo;Company&rdquo;), who beneficially own, in the aggregate, 14,696,905 shares of common
stock, $0.01 par value per share (the &ldquo;Common Stock&rdquo;), of the Company, including 2,447,000 shares underlying call options
that are currently exercisable, constituting approximately 9.32% of the outstanding Common Stock. We are sending this proxy statement
supplement (the &ldquo;Proxy Supplement&rdquo;) and accompanying <B>WHITE </B>proxy card to you in connection with the solicitation
of proxies relating to the upcoming 2021 Annual Meeting of Shareholders (including any and all adjournments, postponements, continuations
or reschedulings thereof, or any other meeting of shareholders held in lieu thereof) (the &ldquo;2021 Annual Meeting&rdquo;) scheduled
to be held virtually on May 12, 2021 at 8:00 a.m. Central Time exclusively online via a live interactive webcast on the internet
for the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">To elect Macellum Badger&rsquo;s five director nominees, Jonathan Duskin, Margaret L. Jenkins,
Jeffrey A. Kantor, Thomas A. Kingsbury and Cynthia S. Murray (each a &ldquo;Nominee&rdquo; and, collectively, the &ldquo;Nominees&rdquo;)
to hold office until the 2022 Annual Meeting of Shareholders (the &ldquo;2022 Annual Meeting&rdquo;) and until their respective
successors have been duly elected and qualified;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">To vote on a non-binding, advisory resolution to approve the compensation of the Company&rsquo;s
named executive officers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">To ratify the appointment of Ernst &amp; Young LLP as the independent registered public accounting
firm of the Company for the fiscal year ending January 29. 2022;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">To vote upon a shareholder proposal regarding the right to act by written consent, if properly
presented at the meeting; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">To transact such other business, if any, as may properly come before the 2021 Annual Meeting and
any adjournment thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">These items of
business are more fully described in the definitive proxy statement filed by Macellum Badger with the Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) on March 15, 2021. For the reasons set forth in our definitive proxy statement, we are soliciting
proxies to elect not only our five (5) Nominees, but also the candidates who have been nominated by the Company, other than Steven
A. Burd, Jonas Prising, John E. Schlifske, Frank V. Sica and Stephanie A. Streeter. This gives shareholders who wish to vote for
our Nominees the ability to vote for all twelve (12) directorships up for election.</P>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">On March 19, 2021,
the Company filed its definitive proxy statement for the 2021 Annual Meeting with the SEC. Accordingly, we are hereby supplementing
our definitive proxy statement with certain information from the Company&rsquo;s definitive proxy statement, which had not been
publicly available at the time we filed our definitive proxy statement, and certain updates to the information contained in our
definitive proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the
Company&rsquo;s definitive proxy statement, the 2021 Annual Meeting will be held virtually on May 12, 2021 at 8:00 a.m. Central
Time. As further described in the Company&rsquo;s definitive proxy statement, due to the continuing public health implications
of the COVID-19 pandemic, the 2021 Annual Meeting will be held exclusively online via a live interactive webcast on the internet.
You will not be able to attend the 2021 Annual Meeting in person at a physical location.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the
Company&rsquo;s definitive proxy statement, all shareholders who owned Common Stock at the close of business on March 24, 2021
(the record date for the 2021 Annual Meeting (the &ldquo;Record Date&rdquo;)) or their duly appointed proxies may attend and vote
at the meeting and at any adjournment of the meeting. Based on the Company&rsquo;s definitive proxy statement, as of March 19,
2021, there were 157,592,637 shares of Common Stock outstanding. Once the Company publicly discloses the number of shares of Common
Stock outstanding as of the Record Date, we intend to provide a supplement with such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company&rsquo;s
definitive proxy statement states that in order to attend the 2021 Annual Meeting, you must pre-register in advance at www.cesonlineservices.com/
kss21_vm prior to the deadline of May 11, 2021 at 8:00 a.m. Central Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the
Company&rsquo;s definitive proxy statement, the following admission procedures for the 2021 Annual Meeting will apply:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Admission to the 2021 Annual Meeting is restricted to shareholders of record as of the Record Date
and/or their designated representatives.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Shareholders and/or their designated representatives will need to pre-register by 8:00 a.m. Central
Time on May 11, 2021, by visiting www.cesonlineservices.com/kss21_vm. Please have your proxy card containing your control number
available and follow the instructions to complete your registration request.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Shareholders whose shares are held in &ldquo;street name&rdquo; through a bank, broker or other
nominee as of the Record Date will need to pre-register by 8:00 a.m. Central Time on May 11, 2021, by visiting www.cesonlineservices.com/kss21_vm.
Please have your voting instruction form or other communication containing your control number available and follow the instructions
to complete your registration request.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Requests to register to participate in the 2021 Annual Meeting must be received no later than 8:00
a.m. Central Time on May 11, 2021.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">After registering, shareholders will receive a confirmation email with a link and instructions
for accessing the 2021 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the
Company&rsquo;s definitive proxy statement, you may present matters for consideration at the 2022 Annual Meeting either by having
the matter included in the Company&rsquo;s proxy statement and proxy card in accordance with Rule 14a-8 under the Securities Exchange
Act of 1934 or by conducting your own proxy solicitation. According to the Company&rsquo;s definitive proxy statement, if you want
your proposal included in the Company&rsquo;s proxy statement and listed on the Company&rsquo;s proxy card for the 2022 Annual
Meeting, the Company must receive your written proposal by November 24, 2021, at Corporate Secretary, Attention: Legal, Kohl&rsquo;s
Corporation, N56 W17000 Ridgewood Drive, Menomonee Falls, Wisconsin 53051. You may submit a proposal only if you meet the ownership
and holding requirements in Rule 14a-8, and you must continue to meet such ownership and holding requirements through the date
of the 2022 Annual Meeting and otherwise comply with the Rule 14a-8 requirements then in effect. According to the Company&rsquo;s
definitive proxy statement, if you decide to conduct your own proxy solicitation, the Company must receive written notice of your
intent to present your proposal at the 2022 Annual Meeting, as required by the Company&rsquo;s Bylaws, by January 12, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the
Company&rsquo;s definitive proxy statement, pursuant to procedures set forth in the Company&rsquo;s Bylaws, the Company&rsquo;s
Governance &amp; Nominating Committee will consider shareholder nominations for directors if the Company receives timely written
notice, in proper form, of the intent to make a nomination at the 2022 Annual Meeting. According to the Company&rsquo;s definitive
proxy statement, if you decide to conduct your own proxy solicitation, to be timely for the 2022 Annual Meeting, the Company must
receive the notice by January 12, 2022. To be in proper form, the notice must comply with the requirements detailed in the Company&rsquo;s
Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In addition, according
to the Company&rsquo;s definitive proxy statement, an eligible shareholder, or a group of up to 20 shareholders, that has continuously
owned at least 3% of the Company&rsquo;s outstanding Common Stock for three years may include in the Company&rsquo;s proxy materials
director nominations of up to the greater of two directors and 20% of the number of directors currently serving on the Board of
Directors of the Company, subject to the terms and conditions specified in the Company&rsquo;s Bylaws. According to the Company&rsquo;s
definitive proxy statement, to be timely for inclusion in the Company&rsquo;s proxy materials for the 2022 Annual Meeting, the
Company&rsquo;s Corporate Secretary must receive your nomination between October 25, 2021, and November 24, 2021. The requirements
for proxy access are detailed in the Company&rsquo;s Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The information
set forth above regarding the procedures for submitting shareholder proposals or nominations for consideration at the 2022 Annual
Meeting is based on information contained in the Company&rsquo;s proxy statement and Bylaws. The inclusion of this information
in this Proxy Supplement should not be construed as an admission by any of the participants in this solicitation that such procedures
are legal, valid or binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Schedule I of our
definitive proxy statement is hereby supplemented as attached hereto to reflect transactions in securities of the Company effected
by the members of the Investor Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Schedule II of our
definitive proxy statement is hereby supplemented as attached hereto to reflect updated beneficial ownership information included
in the Company&rsquo;s definitive proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Whether or not you
plan to attend the 2021 Annual Meeting, we urge you to sign, date and return the enclosed WHITE proxy card in the postage-paid
envelope provided, or vote via the Internet or by telephone as instructed on the WHITE proxy card. Additional information and our
proxy materials can also be found at https://createvalueatkohls.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you need another
copy of our definitive proxy statement or this supplement or if you have any difficulty following the registration process, please
contact Saratoga Proxy Consulting LLC, which is assisting us with our effort to solicit proxies, at the address and toll-free number
set forth on the back cover of this supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This supplement is dated
March 26, 2021, and is first being mailed to shareholders of the Company commencing on or about March 26, 2021. This supplement
should be read in conjunction with Macellum Badger&rsquo;s definitive proxy statement filed with the SEC on, and first furnished
to shareholders on or about, March 15, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THIS SOLICITATION IS BEING
MADE BY THE INVESTOR GROUP AND NOT ON BEHALF OF THE BOARD OF DIRECTORS OR MANAGEMENT OF THE COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">THE INVESTOR GROUP
URGES YOU TO SIGN, DATE AND RETURN THE <B>WHITE</B> PROXY CARD IN FAVOR OF THE ELECTION OF THE NOMINEES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">IF YOU HAVE ALREADY
SENT A PROXY CARD FURNISHED BY COMPANY MANAGEMENT OR THE BOARD, YOU MAY REVOKE THAT PROXY AND VOTE ON EACH OF THE PROPOSALS DESCRIBED
IN OUR DEFINITIVE PROXY STATEMENT BY SIGNING, DATING, AND RETURNING THE ENCLOSED <B>WHITE</B> PROXY CARD. THE LATEST DATED PROXY
IS THE ONLY ONE THAT COUNTS. ANY PROXY MAY BE REVOKED AT ANY TIME PRIOR TO THE 2021 ANNUAL MEETING BY DELIVERING A WRITTEN NOTICE
OF REVOCATION OR A LATER DATED PROXY FOR THE 2021 ANNUAL MEETING OR BY VOTING VIRTUALLY AT THE 2021 ANNUAL MEETING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Important Notice Regarding the Availability
of Proxy Materials for the 2021 Annual Meeting&mdash;This Proxy Supplement, our Definitive Proxy Statement and our WHITE proxy
card are available at</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>www.createvalueatkohls.com</B></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><U>SCHEDULE I</U></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">TRANSACTIONS IN SECURITIES OF THE
COMPANY<BR>
SINCE THE FILING OF OUR DEFINITIVE PROXY STATEMENT</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif"><U>Nature of Transaction</U></TD>
    <TD STYLE="vertical-align: top; width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Amount of Securities</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Purchased/(Sold)</U></P></TD>
    <TD STYLE="vertical-align: top; width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Transaction</U></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Macellum
BADGER Fund, LP</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">10,406</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/18/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of October 15, 2021 Call Options ($85.00 Strike Price)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">16,900</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/18/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($37.50 Strike Price)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(28,200)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/18/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">9,701</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/22/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of October 15, 2021 Call Options ($85.00 Strike Price)<SUP>1</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">18,000</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/22/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($37.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(28,200)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/22/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Macellum
BADGER FUND II, LP</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">358,594</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/18/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of October 15, 2021 Call Options ($85.00 Strike Price)<SUP>1</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">583,100</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/18/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($37.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(971,800)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/18/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">334,299</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/22/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Purchase of October 15, 2021 Call Options ($85.00 Strike Price)<SUP>1</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">622,000</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/22/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($37.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(971,800)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/22/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Catalyst Institutional, LP</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">7,075</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(9,700)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(18,600)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Catalyst, LP</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">609</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(800)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(1,600)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Merlin, LP</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2,332</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/17/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(3,200)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/17/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(6,400)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/17/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
MERLIN Institutional, LP</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">27,568</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/17/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(38,800)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/17/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(74,400)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/17/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Catalyst SPV I LP Series M</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">7,303</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(10,000)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(19,200)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Catalyst SPV I LP Series n</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">5,059</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(6,900)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(13,300)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Catalyst SPV I LP Series O</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">4,983</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(6,800)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(13,100)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Catalyst SPV I LP Series P</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">5,325</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(7,300)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(14,000)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Ancora
Catalyst SPV I SPC Ltd Segregated Portfolio G</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">7,646</TD>
    <TD STYLE="width: 33.33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of January 21, 2022 Call Options ($52.50 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(10,400)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Sale of July 16, 2021 Call Options ($50.00 Strike Price)<SUP>2</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(20,100)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">03/19/2021</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<HR ALIGN="LEFT" SIZE="1" STYLE="width: 5pc; margin-top: 12pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><SUP>1</SUP></FONT> Represents shares of Common Stock underlying American-style call options purchased in the over-the-counter market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT> Represents shares of Common Stock underlying American-style call options sold in the over-the-counter market.</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><U>SCHEDULE II</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>The following table is reprinted from
the Company&rsquo;s definitive proxy statement filed with the Securities and Exchange Commission on March 19, 2021. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITY OWNERSHIP OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The following table presents information
concerning the beneficial ownership of the shares of our common stock as of March 18, 2021 (unless otherwise noted) by:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>each of our Directors and nominees;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>each of our named executive officers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>all of our executive officers, Directors and nominees as a group; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>each person who is known by us to beneficially own more than 5% of our common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Unless otherwise indicated, beneficial
ownership is direct and the person indicated has sole voting and investment power. Indicated options are all exercisable within
sixty days of March 18, 2021.</P>

<!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 58%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Name of Beneficial Owner</B></FONT></TD>
    <TD STYLE="width: 14%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Amount Beneficially Owned</B></FONT></TD>
    <TD STYLE="width: 14%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 14%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Percent of Class</B></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Michael J. Bender</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">10,713</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Peter Boneparth</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">35,707</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Steven A. Burd</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">29,025</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Yael Cosset</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">12,971</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">H. Charles Floyd</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">14,100</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(5)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Robbin Mitchell</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">1,984</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(6)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Jonas Prising</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">44,270</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(7)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">John E. Schlifske</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">37,734</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(8)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Adrianne Shapira</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">17,455</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(9)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Frank V. Sica</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">49,932</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(10)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Stephanie A. Streeter</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">38,709</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(11)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Michelle Gass</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">589,099</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(12)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Jill Timm</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">124,241</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(13)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Doug Howe</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">110,602</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(14)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Greg Revelle</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">155,322</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(15)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Jason Kelroy</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">138,468</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(16)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">All Directors and executive officers as a group (18 persons)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">1,557,605</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(17)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Macellum Advisors GP, LLC; Legion Partners Asset Management, LLC;
        Ancora Holdings, Inc.; 4010 Partners</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Multiple addresses noted in footnote below</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">14,950,605</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(18)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">9.5%</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">The Vanguard Group<BR>
100 Vanguard Blvd.<BR>
Malvern, PA 19355</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">13,917,049</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(19)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">8.83%</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">Blackrock, Inc.<BR>
55 East 52nd Street<BR>
New York, NY 10055</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">13,235,074</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(20)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">8.4%</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">T. Rowe Price Associates, Inc.<BR>
100 E. Pratt Street<BR>
Baltimore, MD 21202</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">8,956,927</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(21)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">5.6%</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">State Street Corporation<BR>
One Lincoln Street<BR>
Boston, MA 02111</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">5,015,317</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><SUP>(22)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">3.18%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>*</I></TD><TD STYLE="text-align: justify"><I>Less than 1%.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(1)</I></TD><TD STYLE="text-align: justify"><I>Includes 7,655 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(2)</I></TD><TD STYLE="text-align: justify"><I>Includes 8,267 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(3)</I></TD><TD STYLE="text-align: justify"><I>Includes 7,655 unvested restricted shares and 2,843 shares represented by stock options.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(4)</I></TD><TD STYLE="text-align: justify"><I>Includes 12,971 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(5)</I></TD><TD STYLE="text-align: justify"><I>Includes 1,984 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(6)</I></TD><TD STYLE="text-align: justify"><I>Includes 1,984 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(7)</I></TD><TD STYLE="text-align: justify"><I>Includes 8,879 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(8)</I></TD><TD STYLE="text-align: justify"><I>Includes 7,655 unvested restricted shares and 7,784 shares represented by stock options.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(9)</I></TD><TD STYLE="text-align: justify"><I>Includes 7,655 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(10)</I></TD><TD STYLE="text-align: justify"><I>Includes 19,902 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(11)</I></TD><TD STYLE="text-align: justify"><I>Includes 9,186 unvested restricted shares and 6,812 shares represented by stock options.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(12)</I></TD><TD STYLE="text-align: justify"><I>Includes 246,476 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(13)</I></TD><TD STYLE="text-align: justify"><I>Includes 104,185 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(14)</I></TD><TD STYLE="text-align: justify"><I>Includes 73,935 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(15)</I></TD><TD STYLE="text-align: justify"><I>Includes 75,307 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(16)</I></TD><TD STYLE="text-align: justify"><I>Includes 109,915 unvested restricted shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(17)</I></TD><TD STYLE="text-align: justify"><I>Includes 808,587 unvested restricted shares and 17,439 shares represented by stock options.</I></TD></TR></TABLE>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(18)</I></TD><TD STYLE="text-align: justify"><I>According to the amended Schedule 13D filed March 12, 2021 , Based on its amended Schedule 13D
filed on March 12, 2021 , a group consisting of Macellum Badger Fund, LP, Macellum Badger Fund II, LP, Macellum Advisors, LP, Macellum
Advisors GP, LLC, Jonathan Duskin, Legion Partners Holdings LLC, Legion Partners, L.P. I, Legion Partners, L.P. II, Legion Partners
Special Opportunities, L.P. XV, Legion Partners, LLC, Legion Partners Asset Management, LLC, Christopher S. Kiper, Raymond T. White,
Ancora Catalyst Institutional, LP, Ancora Catalyst, LP, Ancora Merlin, LP, Ancora Merlin Institutional, LP, Ancora Catalyst SPV
I LP Series M, a series of Ancora Catalyst SPV I LP, Ancora Catalyst SPV I LP Series N, a series of Ancora Catalyst SPV I LP, Ancora
Catalyst SPV I LP Series O, a series of Ancora Catalyst SPV I LP, Ancora Catalyst SPV I LP Series P, a series of Ancora Catalyst
SPV I LP, Ancora Catalyst SPV I SPC Ltd Segregated Portfolio G, Ancora Advisors, LLC, Ancora Alternatives LLC, Ancora Family Wealth
Advisors, LLC, The Ancora Group Inc., Inverness Holdings, LLC, Ancora Holdings, Inc., Frederick DiSanto, 4010 Partners, LP, 4010
Capital, LLC, 4010 General Partner, LLC, Steven E. Litt, Margaret L. Jenkins, Jeffrey A. Kantor, Thomas A. Kingsbury, and Cynthia
S. Murray, disclosed that it beneficially owned the number of shares reported in the table as of February 19, 2021, which includes
3,481,600 shares underlying call options currently exercisable. Macellum Badger Fund LP stated that it beneficially owned and had
shared power to vote or direct vote and shared power to dispose or direct the disposition of 273,611 shares. Macellum Badger Fund
II, LP stated it beneficially owned and had shared power to vote or direct vote and shared power to dispose or direct the disposition
of 8,443,121 shares. Macellum Advisors, LP stated that as the investment manager of Macellum Badger Fund LP and Macellum Badger
Fund II, LP, Macellum Advisors, LP may be deemed the beneficial owner of the 273,611 shares beneficially owned by Macellum Badger
Fund LP and 8,443,121 shares beneficially owned by Macellum Badger Fund II, LP; with shared power to vote or direct vote and shared
power to dispose or direct the disposition of 8,716,732 shares. Macellum Advisors GP, LLC stated that as the general partner of
Macellum Badger Fund LP, Macellum Badger Fund II, LP and Macellum Advisors, LP, Macellum Advisors GP, LLC may be deemed the beneficial
owner of the 273,611 shares beneficially owned by Macellum Badger Fund LP, and 8,443,121 beneficially owned by Macellum Badger
Fund II, LP; with shared power to vote or direct vote and shared power to dispose or direct the disposition of 8,716,732 shares.
Jonathan Duskin stated that, as the sole member of Macellum Advisors GP, LLC, Jonathan Duskin may be deemed the beneficial owner
of the 273,611 shares beneficially owned by Macellum Badger Fund LP, and 8,443,121 shares beneficially owned by Macellum Badger
Fund II, LP; with shared power to vote or direct vote and shared power to dispose or direct the disposition of 8,716,732 shares.
Legion Partners Holdings LLC stated that it beneficially owned directly 100 shares in record name. As the sole member of Legion
Partners Asset Management, LLC and sole member of Legion Partners, LLC, Legion Partners Holdings LLC stated it may be deemed the
beneficial owner of the (i) 1,891,990 shares beneficially owned by Legion Partners, L.P. I; (ii) 111,360 shares beneficially owned
by Legion Partners, L.P. II; and (iii) 108,400 shares beneficially owned by Legion Partners Special Opportunities, L.P. XV; with
shared power to vote or direct vote and shared power to dispose or direct the disposition of 2,111,850 shares. Legion Partners,
L.P. I stated that it beneficially owned directly 1,891,990 shares, with shared power to vote or direct vote and shared power to
dispose or direct the disposition of 1,891,990 shares. Legion Partners, L.P. II stated that it beneficially owned directly 111,360
shares, with shared power to vote or direct vote and shared power to dispose or direct the disposition of 111,360 shares. Legion
Partners Special Opportunities, L.P. XV stated that it beneficially owned directly 108,400 shares, with shared power to vote or
direct vote and shared power to dispose or direct the disposition of 108,400 shares. Legion Partners, LLC stated that as the general
partner of each of Legion Partners, L.P. I and Legion Partners, L.P. II and co-general partner of Legion Partners Special Opportunities,
L.P. XV, Legion Partners, LLC may be deemed the beneficial owner of the (i) 1,891,990 shares beneficially owned by Legion Partners,
L.P. I; (ii) 111,360 shares beneficially owned by Legion Partners, L.P. II; and (iii) 108,400 shares beneficially owned by Legion
Partners Special Opportunities, L.P. XV; with shared power to vote or direct vote and shared power to dispose or direct the disposition
of 2,111,750 shares. Legion Partners Asset Management, LLC stated that as the investment advisor of each of Legion Partners, L.P.
I, Legion Partners, L.P. II and Legion Partners Special Opportunities, L.P. XV, Legion Partners Asset Management, LLC may be deemed
the beneficial owner of the (i) 1,891,990 shares beneficially owned by Legion Partners, L.P.; (ii) 111,360 shares beneficially
owned by Legion Partners, L.P. II; and (iii) 108,400 shares beneficially owned by Legion Partners Special Opportunities, L.P. XV;
with shared power to vote or direct vote and shared power to dispose or direct the disposition of 2,111,750 shares. Christopher
S. Kiper and Raymond T. White stated that as a managing director of Legion Partners Asset Management, LLC and a managing member
of Legion Partners Holdings LLC, they may be deemed the beneficial owner of the (i) 1,891,990 shares beneficially owned by Legion
Partners, L.P. I; (ii) 111,360 shares beneficially owned by Legion Partners, L.P. II; (iii) 108,400 shares beneficially owned by
Legion Partners Special Opportunities, L.P. XV; and (iv) 100 shares held in record name by Legion Partners Holdings LLC; with shared
power to vote or direct vote and shared power to dispose or direct the disposition of 2,111,850 shares. Ancora Catalyst Institutional,
LP stated that it beneficially owned directly 553,445 shares, with shared power to vote or direct vote and shared power to dispose
or direct the disposition of 553,445 shares. Ancora Catalyst, LP stated that it beneficially owned directly 43,867 shares, with
shared power to vote or direct vote and shared power to dispose or direct the disposition of 43,867 shares. Ancora Merlin, LP stated
that it beneficially owned directly 43,283 shares, with shared power to vote or direct vote and shared power to dispose or direct
the disposition of 43,283 shares. Ancora Merlin Institutional, LP stated that it beneficially owned directly 549,030 shares, with
shared power to vote or direct vote and shared power to dispose or direct the disposition of 549,030 shares. Ancora Catalyst SPV
I LP Series M, a series of Ancora Catalyst SPV I LP, stated that it beneficially owned directly 601,401 shares, with shared power
to vote or direct vote and shared power to dispose or direct the disposition of 601,401 shares. Ancora Catalyst SPV I LP Series
N, a series of Ancora Catalyst SPV I LP, stated that it beneficially owned directly 424,050 shares, with shared power to vote or
direct vote and shared power to dispose or direct the disposition of 424,050 shares. Ancora Catalyst SPV I LP Series O, a series
of Ancora Catalyst SPV I LP, stated that it beneficially owned directly 417,670 shares, with shared power to vote or direct vote
and shared power to dispose or direct the disposition of 417,670 shares. Ancora Catalyst SPV I LP Series P, a series of Ancora
Catalyst SPV I LP, stated that it beneficially owned directly 423,820 shares, with shared power to vote or direct vote and shared
power to dispose or direct the disposition of 423,820 shares. Ancora Catalyst SPV I SPC Ltd Segregated Portfolio G stated that
it beneficially owned directly 592,000 shares, with shared power to vote or direct vote and shared power to dispose or direct the
disposition of 592,000 shares. Ancora Advisors, LLC stated that 422,259 shares were held in a certain separately managed account,
and that as the investment advisor to the certain separately managed account, it may be deemed to beneficially own the 422,259
shares held in the certain separately managed account, with shared power to vote or direct vote and shared power to dispose or
direct the disposition of 422,259 shares. Ancora Alternatives LLC stated that, as the investment advisor to each of Ancora Catalyst
Institutional, LP, Ancora Catalyst, LP, Ancora Merlin, LP, Ancora Merlin Institutional, LP, Ancora Catalyst SPV I LP Series M,
a series of Ancora Catalyst SPV I LP, Ancora Catalyst SPV I LP Series N, a series of Ancora Catalyst SPV I LP, Ancora Catalyst
SPV I LP Series O, a series of Ancora Catalyst SPV I LP, Ancora Catalyst SPV I LP Series P, a series of Ancora Catalyst SPV I LP,
and Ancora Catalyst SPV I SPC Ltd Segregated Portfolio G, it may be deemed the beneficial owner of the (i) 553,445 shares beneficially
owned by Ancora Catalyst Institutional, LP; (ii) 43,867 shares beneficially owned by Ancora Catalyst, LP; (iii) 48,283 shares beneficially
owned by Ancora Merlin, LP; (iv) 549,030 shares beneficially owned by Ancora Merlin Institutional, LP; (v) 601,401 shares beneficially
owned by Ancora Catalyst SPV I LP Series M, a series of Ancora Catalyst SPV I LP; (vi) 424,050 shares beneficially owned by Ancora
Catalyst SPV I LP Series N, a series of Ancora Catalyst SPV I LP; (vii) 417,670 shares beneficially owned by Ancora Catalyst SPV
I LP Series O, a series of Ancora Catalyst SPV I LP; (viii) 423,820 shares beneficially owned by Ancora Catalyst SPV I LP Series
P, a series of Ancora Catalyst SPV I LP; and (ix) 592,000 shares beneficially owned by Ancora Catalyst SPV I SPC Ltd Segregated
Portfolio G; with shared power to vote or direct vote and shared power to dispose or direct the disposition of 3,653,566 shares.
Ancora Family Wealth Advisors, LLC stated that as the investment advisor of certain separately managed accounts, Ancora Family
Wealth Advisors, LLC may be deemed the beneficial owner of the 7,198 shares held in certain separately managed accounts, with shared
power to vote or direct vote and shared power to dispose or direct the disposition of 7,198 shares. The Ancora Group Inc. stated
that as the sole member of Ancora Advisors, LLC, it may be deemed to beneficially own the 422,259 shares held in Ancora Advisors,
LLC&rsquo;s certain separately managed account with shared power to vote or direct vote and shared power to dispose or direct the
disposition of 422,259 shares. Inverness Holdings, LLC stated that as the sole member of Ancora Family Wealth Advisors, LLC, may
be deemed to beneficially own the 7,198 shares in the certain separately managed accounts, with shared power to vote or direct
vote and shared power to dispose or direct the disposition of 7,198 shares. Ancora Holdings, Inc., stated that as the sole member
of each of Ancora Alternatives LLC and Inverness Holdings, LLC and the sole shareholder of The Ancora Group Inc., it may be deemed
the beneficial owner of the (i) 553,445 shares beneficially owned by Ancora Catalyst Institutional, LP; (ii) 43,867 shares beneficially
owned by Ancora Catalyst, LP; (iii) 48,283 shares beneficially owned by Ancora Merlin, LP; (iv) 549,030 shares beneficially owned
by Ancora Merlin Institutional, LP; (v) 601,401 shares beneficially owned by Ancora Catalyst SPV I LP Series M, a series of Ancora
Catalyst SPV I LP; (vi) 424,050 shares beneficially owned by Ancora Catalyst SPV I LP Series N, a series of Ancora Catalyst SPV
I LP; (vii) 417,670 shares beneficially owned by Ancora Catalyst SPV I LP Series O, a series of Ancora Catalyst SPV I LP; (viii)
423,820 shares beneficially owned by Ancora Catalyst SPV I LP Series P, a series of Ancora Catalyst SPV I LP; (ix) 592,000 shares
beneficially owned by Ancora Catalyst SPV I SPC Ltd Segregated Portfolio G; (x) 422,259 shares held in Ancora Advisors, LLC&rsquo;s
certain separately managed account; and (xi) 7,198 shares held in certain separately managed accounts; with shared power to vote
or direct vote and shared power to dispose or direct the disposition of 4,083,023 shares. Frederick DiSanto, stated that as Chairman
and Chief Executive Officer of Ancora Holdings, Inc., Frederick DiSanto may be deemed the beneficial owner of the (i) 553,445 shares
beneficially owned by Ancora Catalyst Institutional, LP; (ii) 43,867 shares beneficially owned by Ancora Catalyst, LP; (iii) 48,283
shares beneficially owned by Ancora Merlin, LP; (iv) 549,030 shares beneficially owned by Ancora Merlin Institutional, LP; (v)
601,401 shares beneficially owned by Ancora Catalyst SPV I LP Series M, a series of Ancora Catalyst SPV I LP; (vi) 424,050 shares
beneficially owned by Ancora Catalyst SPV I LP Series N, a series of Ancora Catalyst SPV I LP; (vii) 417,670 shares beneficially
owned by Ancora Catalyst SPV I LP Series O, a series of Ancora Catalyst SPV I LP; (viii) 423,820 shares beneficially owned by Ancora
Catalyst SPV I LP Series P, a series of Ancora Catalyst SPV I LP; (ix) 592,000 shares beneficially owned by Ancora Catalyst SPV
I SPC Ltd Segregated Portfolio G; (x) 422,259 shares held in Ancora Advisors, LLC&rsquo;s certain separately managed account; and
(xi) 7,198 shares held in certain separately managed accounts; with shared power to vote or direct vote and shared power to dispose
or direct the disposition of 4,083,023 shares. 4010 Partners, LP stated that it beneficially owned directly 39,000 shares, with
shared power to vote or direct vote and shared power to dispose or direct the disposition of 39,000 shares. 4010 Capital, LLC,
stated that as the investment manager of 4010 Partners, LP and co-general partner of Legion Partners Special Opportunities, L.P.
XV, it may be deemed the beneficial owner of the 39,000 shares beneficially owned by 4010 Partners, LP; and 108,400 shares beneficially
owned by Legion Partners Special Opportunities, L.P. XV; with shared power to vote or direct vote and shared power to dispose or
direct the disposition of 147,400 shares. 4010 General Partner, LLC stated that as the general partner of 4010 Partners, LP, it
may be deemed the beneficial owner of the 39,000 shares beneficially owned by 4010 Partners, LP, with shared power to vote or direct
vote and shared power to dispose or direct the disposition of 39,000 shares. Steven E. Litt stated that as a managing member of
4010 Capital, LLC, Steven E. Litt may be deemed the beneficial owner of the 39,000 shares beneficially owned by 4010 Partners,
LP; and 108,400 shares beneficially owned by Legion Partners Special Opportunities, L.P. XV; with shared power to vote or direct
vote and shared power to dispose or direct the disposition of 147,400 shares. The remaining members of the group had no sole or
shared voting or dispositive power over any of the reported shares. The address of the principal office of each of Macellum Badger
Fund LP, Macellum Badger Fund II LP, Macellum Advisors, LP, Macellum Advisors GP, LLC and Mr. Duskin is 99 Hudson Street, 5th Floor,
New York, NY 10013. The address of the principal office of each of Legion Partners Holdings, LLC, Legion Partners, L.P. I, Legion
Partners, L.P. II, Legion Partners Special Opportunities, L.P. XV, Legion Partners, LLC, Legion Partners Asset Management, LLC
and Messrs. Kiper and White is 12121 Wilshire Blvd, Suite 1240, Los Angeles, CA 90025. The address of the principal office of each
of Ancora Catalyst Institutional, LP, Ancora Catalyst, LP, Ancora Merlin, LP, Ancora Merlin Institutional, LP, Ancora Catalyst
SPV I LP Series M, a series of Ancora Catalyst SPV I LP, Ancora Catalyst SPV I LP Series N, a series of Ancora Catalyst SPV I LP,
Ancora Catalyst SPV I LP Series O, a series of Ancora Catalyst SPV I LPAncora Catalyst SPV I LP Series P, a series of Ancora Catalyst
SPV I LP, Ancora Advisors, LLC, Ancora Alternatives LLC, Ancora Family Wealth Advisors, LLC, The Ancora Group Inc., Inverness Holdings,
LLC, Ancora Holdings, Inc. and Mr. DiSanto is 6060 Parkland Boulevard, Suite 200, Cleveland, OH 44124. The address of the principal
office of Ancora Catalyst SPV I SPC Ltd Segregated Portfolio G is 94 Solaris Avenue, Box 1348, Camana Bay, Grand Cayman, Cayman
Islands KY1-1108. The address of the principal office of each of 4010 Partners, LP, 4010 Capital, LLC, 4010 General Partner, LLC,
and Mr. Litt is 48 Brookridge Drive, Greenwich, CT 06830. The principal business address of Ms. Jenkins is 18 Tamaron Way, Greer,
SC 29650. The principal business address of Mr. Kantor is 17 Fenbrook Drive, Larchmont, NY 10538. The principal business address
of Mr. Kingsbury is 170 Golf House Road, Haverford, PA 19041. The principal business address of Ms. Murray is 9959 Brassie Bend,
Naples, FL 34108.</I></TD></TR></TABLE>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(19)</I></TD><TD STYLE="text-align: justify"><I>According to the amended Schedule 13G filed February 10, 2021 by The Vanguard Group (&ldquo;Vanguard&rdquo;),
Vanguard and certain affiliated entities were the beneficial owner of 13,917,049 shares of Kohl&rsquo;s common stock as of December
31, 2020. The filing indicates that Vanguard and certain affiliated entities have sole dispositive power with respect to 13,678,836
shares, shared voting power with respect to 107,652 shares and shared dispositive power with respect to 238,213 shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(20)</I></TD><TD STYLE="text-align: justify"><I>According to the amended Schedule 13G filed January 29, 2021 by Blackrock, Inc. (&ldquo;Blackrock&rdquo;),
Blackrock and certain affiliated entities were the beneficial owner of 13,235,074 shares of Kohl&rsquo;s common stock as of December
31, 2020. The filing indicates that Blackrock and certain affiliated entities have sole voting power with respect to 12,579,543
shares and sole dispositive power with respect to 13,235,074 shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(21)</I></TD><TD STYLE="text-align: justify"><I>According to the Schedule 13G filed February 16, 2021 by T. Rowe Price Associates, Inc. (&ldquo;T.
Rowe&rdquo;), T. Rowe and certain affiliated entities were the beneficial owner of 8,965,927 shares of Kohl&rsquo;s common stock
as of December 31, 2020. The filing indicates that T. Rowe and certain affiliated entities have sole voting power with respect
to 4,522,949 shares and sole dispositive power with respect to 8,956,927 shares.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>(22)</I></TD><TD STYLE="text-align: justify"><I>According to the Schedule 13G filed February 16, 2021 by State Street Corporation (&ldquo;State
Street&rdquo;), State Street and certain affiliated entities were the beneficial owner of 5,015,317 shares of Kohl&rsquo;s common
stock as of December 31, 2020. The filing indicates that State Street and certain affiliated entities have shared voting power
with respect to 3,650,194 and shared dispositive power with respect to 5,015,317 shares.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>Your vote is
important, no matter how few shares of Common Stock you own. The Investor Group urges you to sign, date, and return the enclosed
WHITE proxy card today to vote FOR the election of the Nominees and in accordance with the Investor Group&rsquo;s recommendations
on the other proposals on the agenda for the 2021 Annual Meeting.</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">If your shares of Common Stock are registered in your own name, please sign and date the enclosed
<B>WHITE</B> proxy card and return it to the Investor Group, c/o Saratoga Proxy Consulting LLC (&ldquo;Saratoga&rdquo;) in the
enclosed postage-paid envelope today.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">If your shares of Common Stock are held in a brokerage account or bank, you are considered the
beneficial owner of the shares of Common Stock, and these proxy materials, together with a <B>WHITE</B> voting form, are being
forwarded to you by your broker or bank. As a beneficial owner, you must instruct your broker, trustee or other representative
how to vote. Your broker cannot vote your shares of Common Stock on your behalf without your instructions. As a beneficial owner,
you may vote the shares virtually at the 2021 Annual Meeting only if you obtain a legal proxy from the broker or bank giving you
the rights to vote the shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Depending upon your broker or custodian, you may be able to vote either by toll-free telephone
or by the Internet. Please refer to the enclosed voting form for instructions on how to vote electronically. You may also vote
by signing, dating and returning the enclosed voting form.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You may vote your shares virtually at the 2021 Annual Meeting. Even if you plan to attend the 2021
Annual Meeting, we recommend that you submit your <B>WHITE</B> proxy card by mail by the applicable deadline so that your vote
will be counted if you later decide not to attend the 2021 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Since only your
latest dated proxy card will count, we urge you not to return any proxy card you receive from the Company. Even if you return the
Company&rsquo;s proxy card marked &ldquo;withhold&rdquo; as a protest against the incumbent directors, it will revoke any proxy
card you may have previously sent to us. Remember, you can vote for our five Nominees only on our <B>WHITE</B> proxy card. So please
make certain that the latest dated proxy card you return is the <B>WHITE</B> proxy card.</P>

<!-- Field: Page; Sequence: 15; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1in">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>If you have any questions, require assistance
        in voting your <B>WHITE</B> proxy card,</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>or need additional copies of the Investor
        Group&rsquo;s proxy materials,</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>please contact:</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 188px; width: 386px"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Shareholders call toll-free at (888) 368-0379</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Email: info@saratogaproxy.com</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><B>WHITE</B> PROXY CARD</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>KOHL&rsquo;S CORPORATION<BR>
<BR>
2021 ANNUAL MEETING OF SHAREHOLDERS<BR>
<BR>
THIS PROXY IS SOLICITED ON BEHALF OF MACELLUM BADGER, LP AND THE OTHER PARTICIPANTS IN ITS PROXY SOLICITATION<BR>
<BR>
THE BOARD OF DIRECTORS OF KOHL&rsquo;S CORPORATION<BR>
IS NOT SOLICITING THIS PROXY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>P&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;O&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Y</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned
appoints Jonathan Duskin, John Ferguson and Christopher Kiper, and each of them, attorneys and agents with full power of substitution
to vote all shares of Common Stock of Kohl&rsquo;s Corporation (the &ldquo;Company&rdquo;) which the undersigned would be entitled
to vote if personally present at the 2021 Annual Meeting of Shareholders of the Company scheduled to be held virtually online,
via live webcast, on May 12, 2021 at 8:00 am Central Time (including any adjournments or postponements thereof and any meeting
called in lieu thereof, the &ldquo;2021 Annual Meeting&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned
hereby revokes any other proxy or proxies heretofore given to vote or act with respect to the shares of Common Stock of the Company
held by the undersigned, and hereby ratifies and confirms all action the herein named attorneys and proxies, their substitutes,
or any of them may lawfully take by virtue hereof. If properly executed, this Proxy will be voted as directed on the reverse and
in the discretion of the herein named attorneys and proxies or their substitutes with respect to any other matters as may properly
come before the 2021 Annual Meeting that are unknown to Macellum Badger, LP a reasonable time before this solicitation, each of
whom are deemed participants in this solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>THIS PROXY WILL BE VOTED AS DIRECTED.
IF NO DIRECTION IS INDICATED WITH RESPECT TO THE PROPOSALS ON THE REVERSE, THIS PROXY WILL BE VOTED &ldquo;FOR ALL NOMINEES&rdquo;
IN PROPOSAL 1, &ldquo;AGAINST&rdquo; PROPOSAL 2, &ldquo;FOR&rdquo; PROPOSAL 3, AND &ldquo;ABSTAIN&rdquo; FROM PROPOSAL 4.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This Proxy will be valid until the sooner
of one year from the date indicated on the reverse and the completion of the 2021 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Important Notice Regarding the Availability
of Proxy Materials for the 2021 Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>This Proxy Statement and our WHITE
proxy card are available at </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>www.createvalueatkohls.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>IMPORTANT: PLEASE SIGN, DATE AND MAIL
THIS PROXY CARD PROMPTLY!<BR>
<BR>
CONTINUED AND TO BE SIGNED ON REVERSE SIDE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><B>WHITE</B> PROXY CARD</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>[X] Please mark vote as in this example</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><B>THIS PROXY WILL BE VOTED AS DIRECTED.
IF NO DIRECTION IS INDICATED WITH RESPECT TO THE PROPOSALS, THIS PROXY WILL BE VOTED &ldquo;FOR ALL NOMINEES&rdquo; IN PROPOSAL
1, &ldquo;AGAINST&rdquo; PROPOSAL 2, &ldquo;FOR&rdquo; PROPOSAL 3, AND &ldquo;ABSTAIN&rdquo; FROM PROPOSAL 4. MACELLUM BADGER STRONGLY
RECOMMENDS THAT SHAREHOLDERS VOTE &ldquo;FOR ALL NOMINEES&rdquo; LISTED BELOW IN PROPOSAL 1 AND &ldquo;AGAINST&rdquo; PROPOSAL
2. MACELLUM BADGER MAKES NO RECOMMENDATION WITH RESPECT TO PROPOSAL 3 AND PROPOSAL 4.</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">Macellum Badger&rsquo;s proposal to elect Jonathan Duskin, Margaret L. Jenkins, Jeffrey A. Kantor,
Thomas A. Kingsbury and Cynthia S. Murray to the Board to serve as directors with a term expiring at the 2022 annual meeting of
shareholders and until their respective successors are duly elected and qualified.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><B>FOR ALL <BR>
NOMINEES</B></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><B>WITHHOLD <BR>
AUTHORITY TO <BR>
VOTE FOR ALL <BR>
NOMINEES</B></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><B>FOR ALL NOMINEES<BR>
EXCEPT <BR>
NOMINEE(S) <BR>
WRITTEN BELOW</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nominees:</P></TD>
    <TD STYLE="width: 29%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jonathan Duskin</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Margaret L. Jenkins</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jeffrey A. Kantor</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Thomas A. Kingsbury</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Cynthia S. Murray</P></TD>
    <TD STYLE="width: 14%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 25%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Wingdings; margin: 0; text-align: center">&#168;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Macellum Badger intends
to use this proxy to vote (i) &ldquo;FOR&rdquo; Jonathan Duskin, Margaret L. Jenkins, Jeffrey A. Kantor, Thomas A. Kingsbury and
Cynthia S. Murray and (ii) &ldquo;FOR&rdquo; the candidates who have been nominated by the Company to serve as directors, other
than Steven A. Burd, Jonas Prising, John E. Schlifske, Frank V. Sica and Stephanie A. Streeter, for whom Macellum Badger is not
seeking authority to vote for and will not exercise any such authority. The names, backgrounds and qualifications of the candidates
who have been nominated by the Company, and other information about them, can be found in the Company&rsquo;s proxy statement.
There is no assurance that any of the candidates who have been nominated by the Company will serve as directors if our Nominees
are elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 31.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOTE: If you do not
wish for your shares to be voted &ldquo;FOR&rdquo; a particular nominee, mark the &ldquo;FOR ALL NOMINEES EXCEPT NOMINEE(S) WRITTEN
BELOW&rdquo; box and write the name(s) of the nominee(s) you do not support on the line(s) above. Your shares will be voted for
the remaining nominee(s). </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">The Company&rsquo;s proposal to vote on a non-binding, advisory resolution to approve the compensation
of the Company&rsquo;s named executive officers.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 18%; padding-right: 5.75pt; padding-left: 5.75pt">FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 28%; padding-right: 5.75pt; padding-left: 5.75pt">AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 19%; padding-right: 5.75pt; padding-left: 5.75pt">ABSTAIN</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">The Company&rsquo;s proposal to ratify the appointment of Ernst &amp; Young LLP as the independent
registered public accounting firm of the Company for the fiscal year ending January 29, 2022.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 18%; padding-right: 5.75pt; padding-left: 5.75pt">FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 28%; padding-right: 5.75pt; padding-left: 5.75pt">AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 19%; padding-right: 5.75pt; padding-left: 5.75pt">ABSTAIN</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">The shareholder proposal regarding the right to act by written consent.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 18%; padding-right: 5.75pt; padding-left: 5.75pt">FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 28%; padding-right: 5.75pt; padding-left: 5.75pt">AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 5%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 19%; padding-right: 5.75pt; padding-left: 5.75pt">ABSTAIN</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><B>WHITE</B> PROXY CARD</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">DATED: ____________________________<BR>
<BR>
____________________________________<BR>
(Signature)<BR>
<BR>
____________________________________<BR>
(Signature, if held jointly)<BR>
<BR>
____________________________________<BR>
(Title)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">WHEN SHARES ARE HELD JOINTLY, JOINT
OWNERS SHOULD EACH SIGN. EXECUTORS, ADMINISTRATORS, TRUSTEES, ETC., SHOULD INDICATE THE CAPACITY IN WHICH SIGNING. PLEASE SIGN
EXACTLY AS NAME APPEARS ON THIS PROXY.</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "\ 8(# 2(  A$! Q$!_\0
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MYSG%2C&.* %HIK'C/-'>@!U%1,XS@.G'J:<.Q]: 'T4"FM^F* '45@>+=?\
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M/\28(7N_MFRZ"^?G/F<CF@#[.7Z8IU,3H#[4^@ HHHH **** "BBB@ HHHH
M**** (9@'S&QPK+\WT^M>/:]\ [*]OI;[2-5N+665B[!CGD^A%>S$9I,#.:
M/ 5^ >MW!$5[XD,EL>J_,2/S->J^"O ^F>"M.-M9!I)7'[V9NK5U.T$YQS2X
MH !44BK*IC8 AN"#W%34F!0!XUXG^!%GJ>JR:AH^I-I[RL6*'. >Y&*ALO@&
MDR/_ &WKMQ>-MPF&)"GUYKVO%(5!.: /,_A]\*CX&UBXO5U$W"RKMVX[5Z7W
M]!2X H%  ?;TKS+X@?"9/&^LQZ@=0-NR)MVXSFO3N])M&,8H SM$TW^Q]$M=
M.\PR?9HPF['6M(<BD(XIU #6[<9KS7Q[\)-,\877V^&X-G?C[T@Z-]0*]+/-
M(% S@8^E 'AME\ [HRI#J?B2::R7_EDA(K0TKX&6^C^)[;5[+5"L4$@=82O.
M!7L6T>E&T#..]  .@SUH-'N>E [YS0!FZ]HUMK^DSZ9=@F&9<$KU%>&S?L]Z
MK#?.=-UQ8K9C[AL>G%?0F!C'\Z OIQ0!F>'M+DT70K33Y9?.>% I?U_.M3%(
M!CUI<T 5+^RM[^UDMKJ%9H9%(:-N]>-:W\ ()KZ2ZT/4WLU<Y"-_ ?J*]OQF
M@J#U'Z4 >&Z/^SXBW<=QKFK/=A3EHUS\WXFO9]-T^UTNQBLK*%8K>)=JH.U6
M\ #'-&,=J %IAR0V*?37&5(QUXXH \=\:?#WP;XKUZ9(-6BL-8/+QAQM)]Q7
M-7GP>T70-&N]0USQ$;B.*,^3&C8^;MP:Z?Q3\"[?5M5EU/3-5GMKJ1MS;B>O
ML:PD^ &L7+JFH^(WE@'5=S-_.@#G/@)"[^.YY(D+1+&1N]!FOJ#/8GFN8\&^
M!-*\%V!@L4)E<8DF/WGKJ N!CK]: $QQCTZ5Y_X]^%FE^-V%R9/LNH!<>:.X
M^E>A8P** /"[+X!WJLD%[XEN&LE/^IBR,CTJ[#\!+.Q\00ZCI^JND44@81,,
MGCWKV; ':DX)Z#/:@!4!50I)) QGUIU-3&.,?A3J "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HQ110 AHH-(:& 4$XIN3D^E8%_P"+=.L+G[/*[!QV
MQ6<ZB@O>*IPE4=H(Z'/&:,URJ^.M*."7;GVKH+>Z2\M%GA)*L,CBB%6,_A9=
M2C.&DE8F>XB3AY%4^A--^UP?\]4_.O#OB%=72>,)42XF1%C!VJY'-<M]LN\#
M-W/_ -_#4SJ\KL>QA\E=:FIJ1]-_:X/^>J?G2?:H/^>J?G7S+]LNO^?N?_OX
M:3[9=?\ /W/_ -_#4^W-O]7Y?SGTW]J@_P">J?G2&\MP<&9!^-?,PO+O_G[F
M_P"^S2QWMV9X_P#3)OO#^,U4:J9,LB<4WS'TX&#8XR.N:^;_ ![\5?%>B>,K
MZRLKR-+>-@%!3-?0.A,6T:U+,6)0<GZ5\VZ_HMMK?Q9UJ&Z&Y(HS(%+!0Q'N
M36R/!G'EDT9O_"Z_&X_Y?X?^_7_UZ3_A=GC?'_']#_WZ_P#KU+:^%=#N[\[9
M SI$TDD'F# /;YAQ27G@S38IDF^=5$1D:WB8.7^F*"!@^-GC@_\ +]#_ -^O
M_KT@^-?C<G'VZ'_OU_\ 7J"/PWI5_#97EO;W,$,TGDO%)][)_B'L*?J'A#2=
M,UJ#19IG9IUREVG*$^E $I^-7C?C_3X?^_?_ ->D/QK\;#_E_A_"/_Z]9-UX
M=L5\46^@6T[,0<3RG@$^U2R:-I5WJL>E0VEY;MYWE^>XPIQ0!I#XU>-R#B^B
M./2+_P"O1_PNKQQ_S_0_]^O_ *]5QX=TN^>[L[>VN;2:SY,TO"N <$?C5J]\
M!6!^UW6FSO+9VT(:52071_0CTH ;_P +K\< 9^WP_3R__KTA^-GC8];^$?\
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M?#O_ #ZM_P!]4?\ "M?#O_/JW_?51[ ZO]8*/8\'W*/XA2HR^<AR/O"O=_\
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MXH UZ*HZGK&FZ- D^J:C:6,+ML62ZF6)6;K@%B!G /%6Q(&0.K*4."K Y!%
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M++['I.GV]G;Y!*0QA=QQC+=V. .3DUHT %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $[TULYQ3Z3
M-)JX'!MX'O&\$#2Q<6\>K6UY/>V5PI8I'(TKNH)P#@JY5ACHQZU _@"<Z'X6
M2>TTG4[O1;4VTMK>@M;SAE4,0Q1BI!0$'8>XXSFO0]J^E&!3ZW XY_"DK^$[
MBRL]/T;2;UIUNK:.PC*PQ2HRLA9@H+\IRP0<'&.,FFW@G4))M%WW%JT(1#K"
M!F_?R1R>>I3CYAYK/G=CAN]=VV%[5%;74%[;17%K-'/;R+N26-@RL#W!&0:
M)".V.U<MI_A.5/!>JZ!>2QJ;^2\^>')V),[LO7'(##CIQ75$Y%(,>V.](1R"
M:'KVHR:);:P--BM-*F2X,MI,[R7+QJ53Y&11&,G<?F?H%'7-6;'P]=6^G>);
M=Y+<MJMU/- 58X59(U4;N.N1SC-=#<W,%K;F:XFCAB7&9)2 H)( R3QU/YU-
MGT.?UHZ#. TG1+WX>Z7]IAFMCI<>G^9?6K,W[NY1!^\AXY#D$,IQS@CDD'L-
M'FO[C1+*;5(8X;^2!&N(XP0J.5!8#)/0\=:O9_\ K"C=GM1HT&QPS>![UO!
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M*Q#(OEC#,V,OU SQD@T[Q,?'']MG3])%J;3[$4&HR;]GF;M^/(QNQQMSC/\
M%78KR.:7 /:F!YS>^"]8FT_7]&6WTBXM=7NWG.HW$K^?$KD$$Q^60[1]$/F
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MQ[8U^5'BP=I4M@..IQS71Z3X+?1II7MO$FL-Y\YN+@2I:MYSGKN8P[B,<=>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 0@'J* H%+10 F!Z4N*** $P,8Q0% I:* $VBC:/2EHH 3 HVBEHH 3
M-&T4M% ";1Z4;1G.*6B@ Q1110 4444 %%%% !1110 4444 %%%% !1110 4
..444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
